Literature DB >> 8932502

New prospects in the prevention of otitis media.

T Heikkinen1, O Ruuskanen.   

Abstract

Otitis media is the most common bacterial infection in children, accounting for a substantial economic burden to the health care system. Together with concern for long-term developmental sequelae, prevention of otitis media has become a high priority area of research. A wide range of factors has been associated with an increased risk of acute otitis media. Most of these factors, however, predispose to upper respiratory tract infection which, in turn, can be considered the most important risk factor for acute otitis media. Conventionally, antimicrobial prophylaxis, tympanostomy tubes and adenoidectomy have been used for prevention of otitis media. At present, the vaccine approach seems to hold the greatest promise for ultimate prevention of otitis media. In addition to the bacterial vaccines, vaccines against the most common viruses predisposing to acute otitis media may also prove valuable in the prevention of otitis media.

Entities:  

Mesh:

Year:  1996        PMID: 8932502     DOI: 10.3109/07853899608999070

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  4 in total

Review 1.  Risk factors for the development of otitis media.

Authors:  Ingeborg J M Dhooge
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

2.  A global theme issue: bibliography of references.

Authors:  M A Winker
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

3.  Current opinion in the management in acute otitis media.

Authors:  A K Bhattacharyya; S Ghodh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1998-04

4.  Intranasal fluticasone propionate does not prevent acute otitis media during viral upper respiratory infection in children.

Authors:  A Ruohola; T Heikkinen; M Waris; T Puhakka; O Ruuskanen
Journal:  J Allergy Clin Immunol       Date:  2000-09       Impact factor: 10.793

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.